GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Cyclically Adjusted Revenue per Share

MKKGY (Merck KGaA) Cyclically Adjusted Revenue per Share : $9.52 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Merck KGaA's adjusted revenue per share for the three months ended in Dec. 2024 was $2.615. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $9.52 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Merck KGaA's average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Merck KGaA was 10.70% per year. The lowest was 5.40% per year. And the median was 9.30% per year.

As of today (2025-05-18), Merck KGaA's current stock price is $25.78. Merck KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $9.52. Merck KGaA's Cyclically Adjusted PS Ratio of today is 2.71.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Merck KGaA was 6.46. The lowest was 2.46. And the median was 3.56.


Merck KGaA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Merck KGaA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Cyclically Adjusted Revenue per Share Chart

Merck KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.91 8.18 8.66 9.70 9.52

Merck KGaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.70 9.61 9.72 10.26 9.52

Competitive Comparison of Merck KGaA's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Cyclically Adjusted PS Ratio falls into.


;
;

Merck KGaA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck KGaA's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=2.615/127.0412*127.0412
=2.615

Current CPI (Dec. 2024) = 127.0412.

Merck KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 1.517 99.717 1.933
201506 1.664 100.417 2.105
201509 1.616 100.417 2.044
201512 1.734 99.717 2.209
201603 1.878 100.017 2.385
201606 1.973 100.717 2.489
201609 1.921 101.017 2.416
201612 1.861 101.217 2.336
201703 1.895 101.417 2.374
201706 1.910 102.117 2.376
201709 1.927 102.717 2.383
201712 1.987 102.617 2.460
201803 1.966 102.917 2.427
201806 2.003 104.017 2.446
201809 2.007 104.718 2.435
201812 2.047 104.217 2.495
201903 1.926 104.217 2.348
201906 2.064 105.718 2.480
201909 2.057 106.018 2.465
201912 2.224 105.818 2.670
202003 2.224 105.718 2.673
202006 2.134 106.618 2.543
202009 2.407 105.818 2.890
202012 2.567 105.518 3.091
202103 2.539 107.518 3.000
202106 2.699 108.486 3.161
202109 2.691 109.435 3.124
202112 2.713 110.384 3.122
202203 2.628 113.968 2.929
202206 2.708 115.760 2.972
202209 2.641 118.818 2.824
202212 2.763 119.345 2.941
202303 2.606 122.402 2.705
202306 2.642 123.140 2.726
202309 2.540 124.195 2.598
202312 2.617 123.773 2.686
202403 2.566 125.038 2.607
202406 2.650 125.882 2.674
202409 2.688 126.198 2.706
202412 2.615 127.041 2.615

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Merck KGaA  (OTCPK:MKKGY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Merck KGaA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=25.78/9.52
=2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Merck KGaA was 6.46. The lowest was 2.46. And the median was 3.56.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Merck KGaA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Industry
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Q4 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 Merck KGaA Earnings Press Conference Transcript

By GuruFocus Research 03-08-2024

Q2 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 08-02-2024

Merck KGaA R&D Update Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2024 Merck KGaA Earnings Call Transcript

By GuruFocus News 11-15-2024

Merck KGaA Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024